# FDA Food Safety Laboratory Gap Analysis for OpenELIS Global 2

## Regulatory Context

This analysis evaluates OpenELIS Global 2's readiness for FDA-regulated food safety laboratories operating under:
- **FSMA** (Food Safety Modernization Act)
- **BAM methods** (Bacteriological Analytical Manual)
- **21 CFR Parts 110/117** (Current Good Manufacturing Practice, Hazard Analysis)

---

## Gap Analysis Table

| Functional Area | OpenELIS Currently Provides | Food Safety Lab Needs | Estimated Effort |
|-----------------|----------------------------|----------------------|------------------|
| **Sample Accession and Chain of Custody** | • Unique accession numbers<br>• Barcode scanning support<br>• Sample status tracking (entered, in lab, released)<br>• GPS coordinates for collection location<br>• Aliquoting with parent-child relationships<br>• Source of sample tracking<br>• Collection date/time and required by dates | • **21 CFR Part 111** chain of custody documentation<br>• Sample custody logs with user signatures<br>• Temperature tracking throughout chain<br>• Hold/destroy flags for recalled samples<br>• Sample retention time tracking<br>• Quarantine status for suspect samples | **Minor Development** - Need custody log entity, temperature tracking fields, retention period calculations, and 21 CFR Part 11 audit trail enhancements |
| **Sample Types and Matrices** | • `TypeOfSample` entity with description, domain, disposal instructions<br>• `TypeOfSampleTest` linking samples to tests<br>• Support for multiple sample types per test<br>• Whonecode support | • Food-specific matrices: produce, meat, dairy, water, surfaces, environmental<br>• Sample preparation protocols (enrichment, homogenization)<br>• Matrix-specific collection instructions<br>• Sample stability windows per matrix<br>• Cross-contamination prevention flags | **Configuration Only** - Create TypeOfSample entries for food matrices; add sample preparation fields via configuration |
| **Test Catalog and Analytical Methods** | • `Test` entity with LOINC, local code, description<br>• `Method` entity for testing methodology<br>• `TestSection` for lab organization<br>• `Panel` for grouped tests<br>• `UnitOfMeasure` with UCUM codes<br>• Test ordering with `orderable` flag | • BAM method references and versions<br>• AOAC method associations<br>• Method validation status tracking<br>• Method proficiency testing records<br>• Reference method comparisons<br>• Method-specific result interpretation rules | **Minor Development** - Add method version field, validation status, proficiency testing linkage; extend Method entity with BAM/AOAC references |
| **Result Entry and Units of Measure** | • `Result` entity with value, result type, significant digits<br>• `TestResult` for qualitative options<br>• `UnitOfMeasure` with UCUM codes<br>• Numeric and qualitative result types<br>• Decimal precision control | • Regulatory unit requirements (CFU/g, ppm, ppb)<br>• Action limit thresholds vs reporting limits<br>• Detection limit tracking<br>• Uncertainty reporting (expanded uncertainty)<br>• Result verification workflows<br>• Out-of-specification result handling | **Configuration Only** - Configure appropriate units; add action limit fields to ResultLimit; create out-of-spec result workflow |
| **Reference Ranges and Action Limits** | • `ResultLimit` entity with normal, valid, reporting ranges<br>• Demographic scoping (gender, age)<br>• Component-level limits (OGC-949 M7)<br>• Sample-type scoped limits (OGC-1145)<br>• Critical value tracking | • **FDA action limits** (not clinical ranges)<br>• Performance criteria (BAM detection limits)<br>• Regulatory thresholds (21 CFR Part 117)<br>• Alert limits for trending<br>• Compliance verification thresholds<br>• Action limit exceedance workflows | **Configuration Only** - Use ResultLimit entity for action limits; add regulatory threshold field; configure exceedance workflows |
| **QA/QC Workflows** | • QC checklists and evaluations<br>• QC control lot tracking<br>• QC result recording<br>• Westgard rule evaluation<br>• QC violation alerts<br>• Calibration tracking | • **BAM method controls**<br>• Blank, spike, and control sample tracking<br>• Method detection capability (MDC)<br>• Recovery verification<br>• Precision studies<br>• Method validation documentation<br>• Proficiency testing integration | **Minor Development** - Add BAM-specific QC types, MDC calculations, recovery tracking fields, proficiency testing linkage |
| **Regulatory Reporting** | • Report definitions and templates<br>• Data export capabilities<br>• FHIR R4 integration<br>• REST API endpoints<br>• Custom report generation | • **FDA Form 483** readiness<br>• State agency reporting formats<br>• Recall notification workflows<br>• Adverse event reporting<br>• Inspection audit trail export<br>• 21 CFR Part 11 compliant reports | **Minor Development** - Add FDA report templates, audit trail export, 21 CFR Part 11 compliant report generation |
| **User Roles and Access Control** | • Role-based access control (RBAC)<br>• Section-level permissions<br>• Menu and module access control<br>• User session management<br>• Audit trail for user actions | • **21 CFR Part 11** electronic signature requirements<br>• Role separation (analyst, reviewer, approver)<br>• Electronic signature capture and verification<br>• Role-based data access (sample, test, result)<br>• Training status tracking<br>• Competency assessment records | **Minor Development** - Add electronic signature entity, role competency tracking, 21 CFR Part 11 signature workflows |

---

## Detailed Findings by Functional Area

### 1. Sample Accession and Chain of Custody

**Current Strengths:**
- Robust sample tracking with unique identifiers
- GPS coordinates for collection location
- Aliquot hierarchy support
- Status lifecycle management

**Gaps:**
- No dedicated custody log entity
- Temperature monitoring not integrated
- No retention period tracking
- Limited quarantine functionality

**Recommendation:** Extend Sample entity with custody log relationship and add temperature tracking fields.

### 2. Sample Types and Matrices

**Current Strengths:**
- Flexible TypeOfSample configuration
- Domain-based organization
- Disposal instructions support

**Gaps:**
- No sample preparation protocol storage
- Limited matrix-specific workflows
- No stability window tracking

**Recommendation:** Configuration-only approach using existing TypeOfSample entity with additional properties.

### 3. Test Catalog and Analytical Methods

**Current Strengths:**
- Comprehensive test definition model
- Method association
- LOINC integration
- Test section organization

**Gaps:**
- No method version tracking
- No validation status field
- No proficiency testing linkage

**Recommendation:** Add method version and validation status fields to Method entity.

### 4. Result Entry and Units of Measure

**Current Strengths:**
- Flexible result types
- UCUM unit support
- Precision control
- Hierarchical results

**Gaps:**
- No action limit distinction
- No detection limit tracking
- No uncertainty reporting

**Recommendation:** Extend ResultLimit for action limits; add uncertainty fields to Result entity.

### 5. Reference Ranges and Action Limits

**Current Strengths:**
- Comprehensive limit types (normal, valid, reporting, critical)
- Demographic scoping
- Component-level limits

**Gaps:**
- No regulatory threshold field
- No action limit exceedance workflow
- No compliance verification

**Recommendation:** Add regulatory threshold field to ResultLimit; create action limit workflow.

### 6. QA/QC Workflows

**Current Strengths:**
- QC checklist management
- Control lot tracking
- Westgard rule evaluation
- QC violation alerts

**Gaps:**
- No BAM-specific QC types
- No detection capability tracking
- No recovery verification

**Recommendation:** Add BAM QC types and recovery tracking fields.

### 7. Regulatory Reporting

**Current Strengths:**
- Flexible report generation
- FHIR integration
- REST API access
- Custom report templates

**Gaps:**
- No FDA-specific report formats
- No 21 CFR Part 11 compliant reports
- No audit trail export

**Recommendation:** Create FDA report templates; add 21 CFR Part 11 compliant export.

### 8. User Roles and Access Control

**Current Strengths:**
- Role-based access control
- Section-level permissions
- Audit trail

**Gaps:**
- No electronic signature support
- No competency tracking
- No role separation for 21 CFR Part 11

**Recommendation:** Add electronic signature entity; implement 21 CFR Part 11 signature workflows.

---

## Summary Recommendations

| Priority | Area | Action |
|----------|------|--------|
| High | Chain of Custody | Add custody log entity, temperature tracking |
| High | Electronic Signatures | Implement 21 CFR Part 11 compliant signatures |
| Medium | Action Limits | Extend ResultLimit for regulatory thresholds |
| Medium | QC Workflows | Add BAM-specific QC types and tracking |
| Medium | Regulatory Reports | Create FDA-compliant report templates |
| Low | Method Tracking | Add version and validation status fields |
| Low | Sample Preparation | Add preparation protocol fields |

---

## Conclusion

OpenELIS Global 2 provides a **solid foundation** for FDA-regulated food safety laboratories. The core data model supports the essential entities needed for food safety testing. The primary gaps are in **regulatory compliance features** (21 CFR Part 11 electronic signatures, chain of custody documentation) and **food safety-specific workflows** (BAM method controls, action limit management).

**Overall Assessment:** The system requires **minor development** to achieve full FDA compliance, with most gaps addressable through configuration and targeted entity extensions.